Back to Results
First PageMeta Content



NOVEN ANNOUNCES COMMENCEMENT OF PHASE 2 STUDY OF INVESTIGATIONAL d-AMPHETAMINE TRANSDERMAL SYSTEM FOR ADHD October 2, 2012 − Miami, FL and New York, NY − Noven Pharmaceuticals, Inc., a whollyowned subsidiary of Hisam
Add to Reading List

Document Date: 2013-06-27 13:51:08


Open Document

File Size: 170,49 KB

Share Result on Facebook
UPDATE